Related Experiment Video
Updated: Aug 9, 2026

Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery
Published on: March 27, 2018
Hybrid coronary revascularization in multivessel coronary artery disease: a systematic review
Antonio Nenna1, Francesco Nappi2, Cristiano Spadaccio3
1Cardiovascular Surgery, Università Campus Bio-Medico di Roma, Via Alvaro del Portillo 200, Rome, 00128, Italy.
Insights
Hybrid coronary revascularization (HCR) offers benefits for multivessel coronary artery disease (CAD) in select patients. However, conventional coronary artery bypass grafting (CABG) remains superior for high-risk individuals with complex disease.
Area of Science:
- Cardiovascular Surgery
- Interventional Cardiology
- Clinical Outcomes Research
Background:
- Multivessel coronary artery disease (CAD) requires effective revascularization strategies.
- Hybrid coronary revascularization (HCR) combines surgical (CABG) and percutaneous (PCI) approaches.
- The optimal role of HCR in CAD management is under investigation.
Purpose of the Study:
- To systematically review the current evidence on hybrid coronary revascularization (HCR).
- To summarize the state-of-the-art of HCR for multivessel coronary artery disease (CAD).
Main Methods:
- Systematic literature search of major databases up to October 2021.
- Inclusion of randomized trials, meta-analyses, and retrospective studies.
- Synthesis of available data on HCR outcomes.
Main Results:
- Evidence includes 3 randomized trials, 10 meta-analyses, and 27 retrospective studies.
- HCR shows greatest benefit in low-to-intermediate risk patients with less complex coronary anatomy.
- Conventional CABG is favored for highly complex disease and high-risk patients regarding adverse events and survival.
Conclusions:
- HCR is a viable approach for specific multivessel CAD patient subsets.
- HCR is not a universal solution and patient selection is crucial.
- Further research is needed to define optimal patient candidates for HCR.
Abstract:
Aim: Hybrid coronary revascularization (HCR) for multivessel coronary artery disease (CAD) integrates coronary artery bypass grafting (CABG) and percutaneous intervention in a planned revascularization strategy. This systematic review summarizes the state of this art of this technique. Methods: Major databases searched until October 2021. Results: The available literature on HCR includes three randomized trials, ten meta-analysis and 27 retrospective studies. The greatest benefits are observed in patients with low-to-intermediate risk and less complex coronary anatomy; highly complex disease and the presence of risk factors favored conventional CABG in terms of adverse events and survival. Conclusion: HCR is an interesting approach for multivessel CAD but should not be considered a 'one-size-fits-all' procedure. Further studies will specify the subset of patients likely to benefit most from this hybrid approach.
Related Concept Videos
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Coronary Artery Disease I: Introduction
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease IV: Preventive Measures
Coronary Artery Disease V: Interprofessional Care
Acute Coronary Syndrome III: Diagnostic Studies

